(Q43906733)

27 November 2017

title

Lipoprotein(a) in American Indians is low and not independently associated with cardiovascular disease. The Strong Heart Study (English)

1 reference

27 November 2017

3

Elisa T Lee

1 reference

27 November 2017

8

Barbara V Howard

1 reference

27 November 2017

5

Thomas K Welty

1 reference

27 November 2017

4

Richard R Fabsitz

1 reference

27 November 2017

Wenyu Wang

1

1 reference

27 November 2017

Dongsheng Hu

series ordinal

2

1 reference

27 November 2017

David C Robbins

series ordinal

6

1 reference

27 November 2017

J L Yeh

series ordinal

7

1 reference

27 November 2017

language of work or name

1 reference

1 February 2002

1 reference

27 November 2017

published in

Annals of Epidemiology

1 reference

27 November 2017

volume

12

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

107-114

1 reference

A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Biologic markers as predictors of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Nontraditional cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Lp(a) lipoprotein is a major risk factor for cardiovascular disease: pathogenic mechanisms and clinical significance.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Lp(a) in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

[Lipoprotein(a) as a risk factor for cardiovascular disease in elderly patients with diabetes].

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Lipoprotein(a) as a risk factor for coronary artery disease in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Lipoprotein (a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Concentrations of Lp(a) in black and white young adults: relations to risk factors for cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Lp(a) concentrations are related to plasma lipid concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Serum lipoprotein(a) and cardiovascular disease in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Racial variation of cord plasma lipoprotein(a) levels in relation to coronary risk level: a study in three ethnic groups in Singapore.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans. The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Cardiovascular disease risk factors among American Indians. The Strong Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years. The Strong Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Parity, postmenopausal estrogen use, and cardiovascular disease risk factors in American Indian women: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Comparison of serum lipoprotein(a) distribution and its correlates among black and white populations

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

The mysteries of lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Lipoprotein(a) in diabetic patients with and without chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Serum lipoprotein(a) in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

Plasma lipoprotein distribution of apolipoprotein(a) in the fed and fasted states.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900273-3

7 January 2021

10.1016/S1047-2797(01)00273-3

Identifiers

DOI

1 reference

release_k6b55g3tqnbvxbksei3afak7si

27 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k6b55g3tqnbvxbksei3afak7si

24 November 2022

mapped directly with Wikidata item

1 reference